LOAMU
ORIAU

Lombard Odier Asset Management (USA)’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ORIAU Stock Details ORIAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$495K – 457
2021
Q3 		$495K Hold
50,000
– – 0.02% 255
2021
Q2 		$503K Buy
+50,000
New +$504K 0.02% 242

Other funds holding ORIAU

JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ORIAU Position: Q4 2021 in Review

Lombard Odier Asset Management (USA) sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2021, closing a stake of 50,000 shares — an estimated $495K sold.

Lombard Odier Asset Management (USA) first reported a position in ORIAU in Q2 2021 and held it in 2 quarters. The position peaked at $503K in Q2 2021. 18 funds tracked by Wall St. Rank hold ORIAU as of Q4 2021.

  • Lombard Odier Asset Management (USA) reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2021 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 50,000 Orion Biotech Opportunities Corp. Units shares in Q4 2021, an estimated $495K.
  • Lombard Odier Asset Management (USA) first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s Orion Biotech Opportunities Corp. Units position peaked at $503K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2021.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2021, filed 14 Feb 2022.